Dr. Boman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4701 Ogletown Stanton Rd
Helen F Graham Cancer Center
Newark, DE 19713Phone+1 302-623-4205Fax+1 215-955-2340
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1982 - 1984
Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Hematology and Medical Oncology, 1980 - 1982- Mayo Clinic College of Medicine and Science (Rochester)Residency, Internal Medicine, 1977 - 1980
University of Minnesota Medical SchoolClass of 1976
Certifications & Licensure
DC State Medical License 1983 - Present
DE State Medical License 2007 - 2025
PA State Medical License 1998 - 2024
MD State Medical License 1983 - 2020
IA State Medical License 1996 - 2000
MN State Medical License 1978 - 1987
TX State Medical License 1985 - 1987- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Rosuvastatin in Treating Patients With Stage I or Stage II Colon Cancer That Was Removed By Surgery Start of enrollment: 2010 Mar 01
Publications & Presentations
PubMed
- 49 citationsIncreased Expression of the Retinoblastoma Gene in Human Colorectal Carcinomas Relative to Normal Colonic MucosaRajalakshmi Gope, Mark A. Christensen, Alan G. Thorson, Henry T. Lynch, Thomas C. Smyrk
Journal of the National Cancer Institute. 1990-02-21 - 18 citationsDoes the human retinoblastoma gene have a role in colon cancerD. M. Wildrick, B. M. Boman
Molecular Carcinogenesis. 1994-05-01 - 803 citationsAldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis.Emina Huang, Mark Hynes, Tao Zhang, Christophe Ginestier, Gabriela Dontu
Cancer Research. 2009-04-15
Journal Articles
- The Anti-Cancer Effect of Retinoic Acid Signaling in CRC Occurs via Decreased Growth of ALDH+ Colon Cancer Stem Cells and Increased Differentiation of Stem CellsBruce Boman, MD, Oncotarget
Press Mentions
ChristianaCare Research May Result in 'More Precise' Advanced Colorectal Cancer TreatmentApril 5th, 2023- Scientists Discover Second Key Pathway in Colon Cancer Stem Cell GrowthOctober 29th, 2020
Key Signaling Pathway Could Lead to New Targets in Colorectal CancerDecember 20th, 2018
Grant Support
- AP4 Center For Studies On Hereditary Colorectal CancerNational Cancer Institute2004
- Proteomic Analyses For GI Stem Cell Markers &MechanismsNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
- Markers For Stem Cell-Like Colonic Crypt Base CellsNational Institute Of Diabetes And Digestive And Kidney Diseases2003–2004
- Characterizing Murine GI Stem Cells: New Molecular ToolsNational Cancer Institute2003–2004
- Core--Gastrointestinal CancerNational Cancer Institute2001–2002
- Approach For Colon Cancer Therapy Using APC PeptidesNational Cancer Institute1996–1998
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
